Features
CAR T-Cell Therapy Brings New Hope to Cancer Patients at Stanford Health Care
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
Get the iPhone MyHealth app »
Get the Android MyHealth app »
Working with many rare forms of blood disorders, the Stanford Hematology Program brings together a multispecialty team of experts dedicated to treating leukemia as well as other benign and malignant hematologic disorders.
Through their laboratory investigation and clinical research, Stanford clinicians are identifying the biologic mechanisms responsible for the development of leukemia, and developing more effective therapies to address these diseases. For example, researchers recently identified a set of 133 genes that point to the most dangerous strains of adult acute myeloid leukemia or AML. In the not so distant future, their research may help doctors pick the best treatment for their AML patients.
With expertise in the basic and clinical sciences, Stanford investigators are delving into the basic origins of blood diseases and in turn translating their findings into the most advanced diagnostic and treatment strategies available today.
As an academic medical institution, the Stanford Cancer Center is committed to improving the standard of care for the millions of individuals worldwide who receive a cancer diagnosis each year. Drawing upon the expertise of more than 240 researchers and clinicians from the Schools of Medicine, Engineering and Humanities & Sciences, the center is at the forefront of today's advances in cancer research and medicine.
CAR T-cell therapy offers a new treatment option for patients with certain blood cancers who did not response to other treatments.
Beverly Mitchell, MD, talks about why she became a doctor and what she loves about her field.
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Bring completed forms found in the Hematology New Patient Letter.
Please fax the Medical Record Release Form to your new patient coordinator. The medical release form is an authorization form for external facilities to release medical records to Stanford Health Care.
International Patients
Phone: +1 650-723-8561
Email: IMS@stanfordhealthcare.org
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referring Physicians.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or e-mail the Referral Center at ReferralCenter@stanfordhealthcare.org
Email or fax a cancer referral form with supporting documentation to ReferralCenter@stanfordhealthcare.org or 650-320-9443.
To make an appointment with one of our cancer specialists, call 650-498-6000.